Study of ARO-033 in adults
This trial tests a new medicine called ARO-033 in adults. It aims to see if it is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult and not pregnant or planning pregnancy.
- Your body mass index (BMI) is between 18 and 35.
- You do not have HIV, hepatitis B, or active hepatitis C.
- Your blood pressure is not too high (under 160/95).
- You have not had major surgery in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This early-phase trial tests a new drug called RO7875913 in healthy volunteers to find the safest dose. It helps researchers understand how the drug works in the body before moving to studies in people with the disease.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.